115 related articles for article (PubMed ID: 10454259)
21. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia.
Schwartz AM; Man YG; Rezaei MK; Simmens SJ; Berg PE
Mod Pathol; 2009 Jan; 22(1):1-6. PubMed ID: 18931648
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
Prostate; 2010 Sep; 70(13):1429-36. PubMed ID: 20687216
[TBL] [Abstract][Full Text] [Related]
23. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and molecular biology of early prostatic neoplasia.
Sakr WA; Ward C; Grignon DJ; Haas GP
Mol Urol; 2000; 4(3):109-13;discussion 115. PubMed ID: 11062364
[TBL] [Abstract][Full Text] [Related]
25. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
[TBL] [Abstract][Full Text] [Related]
26. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
27. Loss of 14-3-3sigma in prostate cancer and its precursors.
Cheng L; Pan CX; Zhang JT; Zhang S; Kinch MS; Li L; Baldridge LA; Wade C; Hu Z; Koch MO; Ulbright TM; Eble JN
Clin Cancer Res; 2004 May; 10(9):3064-8. PubMed ID: 15131044
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.
Uegaki M; Kita Y; Shirakawa R; Teramoto Y; Kamiyama Y; Saito R; Yoshikawa T; Sakamoto H; Goto T; Akamatsu S; Yamasaki T; Inoue T; Suzuki A; Horiuchi H; Ogawa O; Kobayashi T
Carcinogenesis; 2019 Dec; 40(12):1535-1544. PubMed ID: 31058283
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
30. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
31. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Pan CX; Kinch MS; Kiener PA; Langermann S; Serrero G; Sun L; Corvera J; Sweeney CJ; Li L; Zhang S; Baldridge LA; Jones TD; Koch MO; Ulbright TM; Eble JN; Cheng L
Clin Cancer Res; 2004 Feb; 10(4):1333-7. PubMed ID: 14977833
[TBL] [Abstract][Full Text] [Related]
32. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
[TBL] [Abstract][Full Text] [Related]
33. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
34. Biomarker expression in prostatic intraepithelial neoplasia.
Myers RB; Grizzle WE
Eur Urol; 1996; 30(2):153-66. PubMed ID: 8875196
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Elmore LW; Forsythe R; Forsythe H; Bright AT; Nasim S; Endo K; Holt SE
Oncol Rep; 2008 Sep; 20(3):613-7. PubMed ID: 18695913
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
37. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Gurel B; Iwata T; Koh CM; Jenkins RB; Lan F; Van Dang C; Hicks JL; Morgan J; Cornish TC; Sutcliffe S; Isaacs WB; Luo J; De Marzo AM
Mod Pathol; 2008 Sep; 21(9):1156-67. PubMed ID: 18567993
[TBL] [Abstract][Full Text] [Related]
38. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T; Ninck C; Bloch M; Mirlacher M; Koivisto PA; Helin HJ; Mihatsch MJ; Gasser TC; Bubendorf L
Int J Cancer; 2005 Feb; 113(4):619-28. PubMed ID: 15472903
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia.
Matsuzaki P; Cogliati B; Sanches DS; Chaible LM; Kimura KC; Silva TC; Real-Lima MA; Hernandez-Blazquez FJ; Laufer-Amorim R; Dagli ML
J Comp Pathol; 2010 Jan; 142(1):84-8. PubMed ID: 19643431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
